Is EVGDF or JNJ a better dividend investment in 2026?

EVGDF currently yields 3295.98% with a 5% 5-year dividend growth rate. JNJ yields 2.14% with 5.8% growth. The better choice depends on your goal: EVGDF offers higher current income.

What is the dividend yield difference between EVGDF and JNJ?

EVGDF has a forward dividend yield of 3295.98% ($2.00/share annually). JNJ yields 2.14% ($5.20/share annually). The yield gap is 3293.84 percentage points.

Home › Compare › EVGDF vs JNJ

EVGDF vs JNJ: Dividend Comparison 2026

EVGDF yields 3295.98% · JNJ yields 2.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EVGDF wins by $1116807371891.96M in total portfolio value

INVESTMENT

TIME HORIZON10 years

EVGDF

● Live price

3295.98%

Share price

$0.06

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1116807371891.99M

Annual income

$1,053,906,667,983,572,200.00

Full EVGDF calculator →

JNJ

Johnson & Johnson

● Live price

2.14%

Share price

$242.49

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.5K

Annual income

$4,749.88

Full JNJ calculator →

Portfolio growth — EVGDF vs JNJ

📍 EVGDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EVGDF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EVGDF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EVGDF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EVGDF

Annual income on $10K today (after 15% tax)

$280,158.21/yr

After 10yr DRIP, annual income (after tax)

$895,820,667,786,036,400.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$182.28/yr

After 10yr DRIP, annual income (after tax)

$4,037.40/yr

At 15% tax rate, EVGDF beats the other by $895,820,667,786,032,300.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EVGDF + JNJ for your $10,000?

EVGDF: 50%JNJ: 50%

100% JNJ50/50100% EVGDF

Portfolio after 10yr

$558403685946.01M

Annual income

$526,953,333,991,788,500.00/yr

Blended yield

94.37%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EVGDF

No analyst data

Altman Z

-0.6

Piotroski

2/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-5.7% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EVGDF buys

JNJ buys

No recent congressional trades found for EVGDF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEVGDFJNJ

Forward yield	3295.98% ✓	2.14%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$1116807371891.99M ✓	$30.5K
Annual income after 10y	$1,053,906,667,983,572,200.00 ✓	$4,749.88
Total dividends collected	$1112479357641.99M ✓	$15.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: EVGDF vs JNJ ($10,000, DRIP)

Year	EVGDF Portfolio	EVGDF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$340,298	$329,597.89	$10,594	$274.49	+$329.7K → EVGDF
2	$10,846,499	$10,482,380.08	$11,294	$360.69	+$10.84M → EVGDF
3	$323,858,626	$312,252,872.17	$12,133	$476.91	+$323.85M → EVGDF
4	$9,059,946,948	$8,713,418,218.45	$13,156	$635.42	+$9059.93M → EVGDF
5	$237,505,288,527	$227,811,145,292.43	$14,432	$854.61	+$237505.27M → EVGDF
6	$5,835,475,031,632	$5,581,344,372,907.84	$16,056	$1,162.76	+$5835475.02M → EVGDF
7	$134,405,573,630,030	$128,161,615,346,183.62	$18,175	$1,604.53	+$134405573.61M → EVGDF
8	$2,902,582,463,650,687	$2,758,768,499,866,555.50	$21,009	$2,252.68	+$2902582463.63M → EVGDF
9	$58,785,704,587,309,896	$55,679,941,351,203,656.00	$24,911	$3,229.73	+$58785704587.28M → EVGDF
10	$1,116,807,371,891,993,700	$1,053,906,667,983,572,200.00	$30,458	$4,749.88	+$1116807371891.96M → EVGDF

EVGDF vs JNJ: Complete Analysis 2026

EVGDF — Stock

Elevation Gold Mining Corporation acquires, explores for, develops, and operates precious metal properties in the United States. The company explores for gold and silver deposits. Its flagship project is the 100% owned Moss Gold-Silver mine located in Mohave County, Arizona. The company was formerly known as Northern Vertex Mining Corp. and changed its name to Elevation Gold Mining Corporation in September 2021. Elevation Gold Mining Corporation was incorporated in 2007 and is headquartered in Vancouver, Canada.

Full EVGDF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this EVGDF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EVGDF vs SCHD EVGDF vs JEPI EVGDF vs O EVGDF vs KO EVGDF vs MAIN EVGDF vs ABBV EVGDF vs MRK EVGDF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.